CE
AVTR

Mark Christopher Murray

Known title: EVP, Biomaterials & ATCIK: 0001800013

Mark Christopher Murray's purchase track record

How the stock did after each of Mark Christopher Murray's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
6
of 7 since February 28, 2023
Stock higher 6 months later
50%
3 months: 33%
Median 6-month return
-2.4%
3 months: -5.8%
Beat the S&P 500
33%
median -15.2% vs. index
PurchaseStockAmount3 months6 months
8/11/2026CE$98Kpendingpending
8/14/2025CE$84K-6.2%+38.1%
5/23/2025CE$77K-7.3%-27.7%
3/7/2025CE$128K+0.3%-11.8%
3/8/2024CE$93K-5.4%-22.1%
5/12/2023CE$103K+25.7%+18.9%
2/28/2023CE$141K-6.5%+7.0%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 9, 2026

Celanese Sets Q3 Earnings Call for November 3, 2026. Celanese has announced it will hold its third-quarter earnings conference call on November 3, 2026. The company is also mentioned in a new industry report on thermo compression forming, which highlights its role in advanced manufacturing. With the stock trading near its 52-week low, upcoming earnings results may provide clarity on the company's performance.

this person other insiders at CE

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

Avantor to Report Q3 2026 Earnings on October 28. Avantor has scheduled its third-quarter 2026 earnings release for Wednesday, October 28, 2026. Recent coverage notes that the company led peer groups in research tools and consumables during the second quarter. The stock is currently trading near the lower end of its 52-week range, with analysts maintaining a wide target price spread.

this person other insiders at AVTR

Transaction History

CE▲ Buy$98K
CE▲ Buy$0
CE▲ Buy$0
CE▼ Sell$21K
CE▲ Buy$84K
CE▼ Sell$30K
CE▲ Buy$77K
CE▲ Buy$128K
CE▲ Buy$0
CE▼ Sell$25K
CE▼ Sell$66K
CE▲ Buy$93K
CE▼ Sell$19K
CE▼ Sell$57K
CE▲ Buy$103K
CE▲ Buy$141K
CE▼ Sell$15K
AVTR▼ Sell$34K

We use analytics to understand how market-wall is used. No personal data is sold.